# EDGAR Filing Document

**Accession Number:** 0000839087
**File Stem:** 0001213900-26-042214
**Filing Date:** 2026-4
**Character Count:** 10537
**Document Hash:** 0248f60aad066a1ed6407cdfa72333da
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001213900-26-042214.hdr.sgml**: 20260410

**ACCESSION NUMBER**: 0001213900-26-042214

**CONFORMED SUBMISSION TYPE**: SCHEDULE 13D

**PUBLIC DOCUMENT COUNT**: 1

**FILED AS OF DATE**: 20260410

**DATE AS OF CHANGE**: 20260410

**SUBJECT COMPANY**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** VASO Corp
- **CENTRAL INDEX KEY:** 0000839087
- **STANDARD INDUSTRIAL CLASSIFICATION:** ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS [3845]
- **ORGANIZATION NAME:** 08 Industrial Applications and Services
- **EIN:** 112871434
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** SCHEDULE 13D
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 005-44336
- **FILM NUMBER:** 26853386

**BUSINESS ADDRESS:**
- **STREET 1:** 137 COMMERCIAL STREET, STE. 200
- **CITY:** PLAINVIEW
- **STATE:** NY
- **ZIP:** 11803
- **BUSINESS PHONE:** 516-997-4600

**MAIL ADDRESS:**
- **STREET 1:** 137 COMMERCIAL STREET, STE. 200
- **CITY:** PLAINVIEW
- **STATE:** NY
- **ZIP:** 11803

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** VASOMEDICAL, INC
- **DATE OF NAME CHANGE:** 20120606

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** VASOMEDICAL INC
- **DATE OF NAME CHANGE:** 19950517

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** FUTURE MEDICAL PRODUCTS INC /DE/
- **DATE OF NAME CHANGE:** 19920703
**FILED BY**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** Markowitz Joshua
- **CENTRAL INDEX KEY:** 0001645745

**ORGANIZATION NAME:**

**FILING VALUES:**
- **FORM TYPE:** SCHEDULE 13D

**MAIL ADDRESS:**
- **STREET 1:** 3131 PRINCETON PIKE
- **STREET 2:** BLDG. 3D, SUITE 200
- **CITY:** LAWRENCEVILLE
- **STATE:** NJ
- **ZIP:** 08648

### UNITED STATES SECURITIES AND EXCHANGE COMMISSION
**Washington, D.C. 20549**

## SCHEDULE 13D

### Under the Securities Exchange Act of 1934

**VASO Corp**

*(Name of Issuer)*

**Common Stock**

*(Title of Class of Securities)*

**—**

*(CUSIP Number)*

**Kimberly J. Decker**<br>Barley Snyder LLP<br>126 East King Street<br>Lancaster PA 17601<br>717-299-5201

*(Name, Address and Telephone Number of Person Authorized to Receive Notices and Communications)*

**12/19/2018**

*(Date of Event Which Requires Filing of this Statement)*

| **CUSIP No.** | **—** |

---

| | | | |
|:--|:--|:--|:--|
| 1 | Name of reporting person<br>**Joshua Markowitz** | Name of reporting person<br>**Joshua Markowitz** | |
| 2 | Check the appropriate box if a member of a Group (See Instructions)<br>[x] (a)<br>[ ] (b) | Check the appropriate box if a member of a Group (See Instructions)<br>[x] (a)<br>[ ] (b) | |
| 3 | SEC use only | SEC use only | |
| 4 | Source of funds (See Instructions)<br>**PF** | Source of funds (See Instructions)<br>**PF** | |
| 5 | Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)<br>[ ] | Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)<br>[ ] | |
| 6 | Citizenship or place of organization<br>**X1** | Citizenship or place of organization<br>**X1** | |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 7 | Sole Voting Power<br>**350000.00** |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 8 | Shared Voting Power<br>**55738318.00** |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 9 | Sole Dispositive Power<br>**350000.00** |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 10 | Shared Dispositive Power<br>**55738318.00** |
| 11 | Aggregate amount beneficially owned by each reporting person<br>**56088318.00** | Aggregate amount beneficially owned by each reporting person<br>**56088318.00** | |
| 12 | Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)<br>[ ] | Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)<br>[ ] | |
| 13 | Percent of class represented by amount in Row (11)<br>**31.9%** | Percent of class represented by amount in Row (11)<br>**31.9%** | |
| 14 | Type of Reporting Person (See Instructions)<br>**OO** | Type of Reporting Person (See Instructions)<br>**OO** | |

---

**Comment for Reporting Person:** (1) The total reported in Row 11 consists of:  (i) 7,569,595 shares of the Issuer's Common Stock directly beneficially owned by the Joshua Markowitz Family Article Four (C) Non GST Exempt Trust (the "Non-Exempt Trust") of which Mr. Markowitz is co-trustee; (ii) 4,639,430 shares of the Issuer's Common Stock directly beneficially owned by the Joshua Markowitz Family Article Four (C) GST Exempt Trust (the "Exempt Trust" and, collectively with the Non-Exempt Trust, the "Trusts") of which Mr. Markowitz is co-trustee; (iii) 25,714,286 shares owned by Kerns Manufacturing Company of which Mr. Markowitz is majority owner and President; and (iv) 17,815,007 shares owned by Living Data Technology Corp., of which Mr. Markowitz is majority owner.  Decisions with respect to the shares held in the Trusts are made by majority vote of the Trustees.  As a Trustee, Mr. Markowitz may be deemed to have indirect beneficial ownership of securities held by the Trusts and shared power to vote or dispose of those shares.  Decisions with respect to the shares held by Kerns Manufacturing Company and Living Data Technology Corp. are made by their respective boards of directors.  As majority owner of Kerns Manufacturing Company and Living Data Technology Corp., Mr. Markowitz may be deemed to have indirect beneficial ownership of the securities held by those companies and shared power to vote and dispose of such shares.

(2) The percentage reported in Row 13 is calculated in accordance with Rule 13(d)-3(d)(1)(i) and based on an aggregate total of 175,953,035 shares of the Issuer's Common Stock outstanding as of March 27, 2026, as reported by the Issuer in its Annual Report for the period ended December 31, 2025, filed on Form 10-K with the SEC on March 31, 2026.

| **CUSIP No.** | **—** |

---

| | | | |
|:--|:--|:--|:--|
| 1 | Name of reporting person<br>**Stacey Markowitz** | Name of reporting person<br>**Stacey Markowitz** | |
| 2 | Check the appropriate box if a member of a Group (See Instructions)<br>[x] (a)<br>[ ] (b) | Check the appropriate box if a member of a Group (See Instructions)<br>[x] (a)<br>[ ] (b) | |
| 3 | SEC use only | SEC use only | |
| 4 | Source of funds (See Instructions)<br>**OO** | Source of funds (See Instructions)<br>**OO** | |
| 5 | Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)<br>[ ] | Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)<br>[ ] | |
| 6 | Citizenship or place of organization<br>**X1** | Citizenship or place of organization<br>**X1** | |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 7 | Sole Voting Power<br>**0.00** |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 8 | Shared Voting Power<br>**12209025.00** |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 9 | Sole Dispositive Power<br>**0.00** |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 10 | Shared Dispositive Power<br>**12209025.00** |
| 11 | Aggregate amount beneficially owned by each reporting person<br>**12209025.00** | Aggregate amount beneficially owned by each reporting person<br>**12209025.00** | |
| 12 | Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)<br>[ ] | Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)<br>[ ] | |
| 13 | Percent of class represented by amount in Row (11)<br>**6.9%** | Percent of class represented by amount in Row (11)<br>**6.9%** | |
| 14 | Type of Reporting Person (See Instructions)<br>**OO** | Type of Reporting Person (See Instructions)<br>**OO** | |

---

**Comment for Reporting Person:** (3) The total reported in Row 11 consists of:  (i) 7,569,595 shares of the Issuer's Common Stock directly beneficially owned by the Joshua Markowitz Family Article Four (C) Non GST Exempt Trust (the "Non-Exempt Trust") of which Ms. Markowitz is co-trustee; and (ii) 4,639,430 shares of the Issuer's Common Stock directly beneficially owned by the Joshua Markowitz Family Article Four (C) GST Exempt Trust (the "Exempt Trust" and, collectively with the Non-Exempt Trust, the "Trusts") of which Ms. Markowitz is co-trustee.  Decisions with respect to the shares held in the Trust are made by majority vote of the Trustees.  As a Trustee, Ms. Markowitz may be deemed to have indirect beneficial ownership of securities held by the Trusts.

**Item 1. Security and Issuer**

**(a) Title of Class of Securities:**
Common Stock

**(b) Name of Issuer:**
VASO Corp

**(c) Address of Issuer's Principal Executive Offices:**
137 Commercial Street, Suite 200, Plainview, NY, 11803

**Item 4. Purpose of Transaction**

The Reporting Person acquired the Shares for investment purposes.

**Item 5. Interest in Securities of the Issuer**

**(a)**
For information regarding beneficial ownership of each Reporting Person, see items 7-11 of the cover page for each Reporting Person on this Schedule 13D. The voting and dispositive power reported on the cover pages reflect the respective direct and indirect ownership and control relationships described herein.

**(b)**
For information regarding beneficial ownership of each Reporting Person, see items 7-11 of the cover page for each Reporting Person on this Schedule 13D.

**(c)**
No Reporting Person has engaged in any transactions in the Issuer's securities in the past 60 days.

**Item 6. Contracts, Arrangements, Understandings or Relationships With Respect to Securities of the Issuer.**

No Reporting Person has entered into any contracts, arrangements, understandings or relationships with respect to securities of the Issuer except as described herein.

### SIGNATURE

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

**Reporting Person:** Joshua Markowitz

**Signature:** /s/ Joshua Markowitz

**Name/Title:** Joshua Markowitz

**Date:** 04/09/2026

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

**Reporting Person:** Stacey Markowitz

**Signature:** /s/ Stacey Markowitz

**Name/Title:** Stacey Markowitz

**Date:** 04/09/2026